MeCP2, Methyl-CpG Binding Protein 2
By activating GLP-1 receptors in this area, semaglutide signals that the body has sufficient energy stores
As high as 58.8% of the participants had established CVD without chronic kidney disease (CKD) with an additional 13.4% having both CVD and CKD
While data is still being collected and reviewed, the SELECT trial demonstrated a 20% relative reduction in major adverse cardiovascular events in patients treated with semaglutide
When you eat fiber-rich foods, the fiber expands in your stomach, literally filling you up, while GLP-1 binds to receptors in the vagus nerve and brain to activate satiety (feeling full) pathways that curb appetite
Indulge in the luxurious hydration of the APLB Glutathione Niacinamide Body Lotion, specially formulated to brighten, soothe and moisturise without irritation